Core Med Tech Development ApS: Financial statements 2025
CVR: 37703788
Source: annual report 2025, Danish Business Authority
01/05/2024 – 30/04/2025
Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity in the 2025 report amounted to DKK 15,007,343. The solvency ratio was 91.3%.
- Gross Profit
- DKK -220,933
- Profit/Loss
- DKK -99,037
- Equity
- DKK 15,007,343
- Total Assets
- DKK 16,431,096
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -221 t. | -99 t. | 15 mio. | - |
| 2024 | - | -85 t. | 1.6 mio. | 16.1 mio. | - |
| 2023 | - | -32 t. | 1.2 mio. | 16 mio. | - |
| 2022 | - | -13 t. | -4.3 mio. | 16.7 mio. | - |
| 2021 | - | -1.8 mio. | 36 mio. | 27.1 mio. | - |
How creditworthy is Core Med Tech Development ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Core Med Tech Development ApS
Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Christian Schärfe Baltzer-Thomsen and Steffen Vogel. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity in the 2025 report amounted to DKK 15,007,343.